People | January 04, 2026
AstraZeneca elevates Vikram Chand as SVP, Head of R&D for Japan
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
Dr. Chand held several leadership positions within AstraZeneca and the broader biopharmaceutical industry
BaseLaunch has supported 27 biotech companies across multiple modalities and indications
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
Ipratropium Bromide Nasal Solution (Nasal Spray), 0.03% and 0.06% are bioequivalent to Atrovent Nasal Spray, 0.03% and 0.06%, of Boehringer Ingelheim Pharmaceuticals
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Ipratropium Bromide Nasal Solution is indicated for the symptomatic relief of rhinorrhea associated with allergic and nonallergic perennial rhinitis
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Pradaxa Capsules, 110 mg of Boehringer Ingelheim Pharmaceuticals
This product will be manufactured at Lupin’s Pithampur facility in India
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
Ulcerative Colitis (UC) is a chronic, idiopathic, immune-mediated inflammatory bowel disease (IBD) affecting the large intestine
Subscribe To Our Newsletter & Stay Updated
